ADARx Pharmaceuticals (ADRX)
ADARx Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company that focuses on developing siRNA therapeutics to treat a broad spectrum of diseas...
- Open
- --
- High
- --
- Low
- --
- Prev. Close
- --
- Volume
- --
- Turnover
- --
- Avg Price
- --
- Bid/Ask Ratio
- --
- Amplitude
- --
- 52wk High
- --
- Volume Ratio
- --
- Turnover Ratio
- --
- 52wk Low
- --
- Float Mkt Cap
- --
- Market Cap
- --
- P/ETTM
- --
- P/EDynamic
- --
- P/EStatic
- --
- EPSTTM
- --
- EPSDynamic
- --
- EPSStatic
- --
- BVPS
- --
- P/B
- --
- Circulating Supply
- --
- Dividend YieldTTM
- --
- DividendTTM
- --
- Shares
- --
- Min lot size
- --
- Currency
- --
News
- Unusual Whales · 6 hours ago
ADARx Pharmaceuticals Announces the Closing of Full Exercise of Underwriters’ Option to Purchase Additional Shares Granted in Its Initial Public Offering
- PUBT · 17 hours ago
Adarx director Erez Chimovits acquires 61,516 shares worth $1,045,772
- Tip Ranks · 1 day ago, 02:01 AM
Insiders Make Bold Move as ADARx Directors Go on a Multi-Million Dollar Buying Spree
- PUBT · Sep 28 at 04:45 AM
HBM Healthcare Investments invests USD 15.3 million in ADARx IPO, lifts stake to 1.2%
- RenaissanceCapital · Sep 27 at 04:01 PM
US IPO Weekly Winners & Losers
